Revolution Medicines

Revolution Medicines Jobs & Careers

Redwood City, California, United States

WebsiteLinkedIn
Founded
2015
Employees
375
Total Funding
$1.3B
Health CareLife ScienceMedical

Founded by Alexis Borisy, David Pompliano, Mark A. Goldsmith, Martin D. Burke in 2015.

About Revolution Medicines

Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers. The company’s R&D pipeline comprises RAS(ON) inhibitors designed to suppress diverse oncogenic variants of RAS proteins. The company’s RAS(ON) inhibitors daraxonrasib (RMC-6236), a RAS(ON) multi-selective inhibitor; elironrasib (RMC-6291), a RAS(ON) G12C-selective inhibitor; zoldonrasib (RMC-9805), a RAS(ON) G12D-selective inhibitor; and RMC-5127, a RAS(ON) G12V-selective inhibitor, are currently in clinical development.

Open Jobs at Revolution Medicines (271)

Discover Revolution Medicines and thousands of other companies hiring around the world on TheJobsMap.